Details for New Drug Application (NDA): 214209
✉ Email this page to a colleague
The generic ingredient in SUMATRIPTAN is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 214209
Tradename: | SUMATRIPTAN |
Applicant: | Cipla |
Ingredient: | sumatriptan |
Patents: | 0 |
Pharmacology for NDA: 214209
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 214209
Suppliers and Packaging for NDA: 214209
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUMATRIPTAN | sumatriptan | SPRAY;NASAL | 214209 | ANDA | Cipla USA Inc. | 69097-644 | 69097-644-48 | 6 CONTAINER in 1 BOX (69097-644-48) / 1 SPRAY in 1 CONTAINER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 20MG/SPRAY | ||||
Approval Date: | Feb 22, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription